| Name | Title | Contact Details |
|---|---|---|
Sven Davies |
Vice President of Information Technology | Profile |
INTEGRIS Health is Oklahoma`s largest health system with hospitals, rehabilitation centers, physician clinics, mental health facilities, independent living centers and home health agencies located throughout the state. INTEGRIS Health is a not-for-profit corporation. It was organized under the laws of the state of Oklahoma for charitable, scientific and educational purposes and specifically to engage in the delivery of health-care services and related activities. INTEGRIS Health is governed by an 11 to 15-member board of directors made up of business and community leaders from across the state. It`s managed by President and Chief Executive Officer Bruce Lawrence, with the assistance of senior staff in the areas of physician services, facility operations, strategic services and finance. INTEGRIS Health is a not-for-profit corporation formed in 1983 to serve as the parent corporation for, and to provide management and administrative support to, INTEGRIS Baptist Medical Center Inc., another Oklahoma not-for-profit corporation that operates a tertiary care hospital in northwest Oklahoma City. In 1994, INTEGRIS Health merged with Baptist Healthcare of Oklahoma, an event that brought to the organization a network of outstanding rural hospitals across the state. In 1995, INTEGRIS Health merged with Southwest Medical Center, an acute-care hospital in southwest Oklahoma City. Each of these organizations brings a rich history of serving Oklahomans. INTEGRIS Health, along with these and a number of other affiliated entities, form the INTEGRIS Health system.
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Unbound Medicine, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Media, VA. To find more information about Unbound Medicine, Inc., please visit www.unboundmedicine.com
Helping people experience healthier lives by connecting them to the care, support, and community they need.
Clemente Ambulance is a Struthers, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.